US2008020012A1PendingUtilityA1

Collagen scaffolds, medical implants with same and methods of use

61
Individually held — no corporate assignee on recordPriority: Jun 22, 2006Filed: Jun 22, 2007Published: Jan 24, 2008
Est. expiryJun 22, 2026(expired)· nominal 20-yr term from priority
Inventors:Young Min JuFrancis MoussyThomas J. Koob
A61L 27/24A61L 31/10A61L 31/129A61B 5/14542A61L 27/34A61L 2400/02A61L 27/54A61L 27/18A61B 5/1486A61L 31/044A61B 5/14865A61L 2400/18A61L 27/56A61L 2420/02A61L 27/48
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The subject invention concerns non-degradable three dimensional porous collagen scaffolds and coatings. These scaffolds can be prepared around sensors for implantation into a body. A specific embodiment of the invention concerns implantable glucose sensors. Sensors comprising a collagen scaffold of the invention have improved biocompatibility by minimizing tissue reactions while stimulating angiogenesis. The subject invention also concerns methods for preparing collagen scaffolds of the invention. The subject invention also concerns sensors that have a collagen scaffold of the invention around the exterior of the sensor.

Claims

exact text as granted — not AI-modified
1 . A biocompatible collagen scaffold and/or coating for use with a device implantable in the body or tissue of a person or animal, wherein said collagen scaffold or coating is embedded within a polymer matrix.  
     
     
         2 . The collagen scaffold according to  claim 1 , wherein said collagen scaffold is treated with a cross-linking compound comprising a reactive catechol at a pH sufficient to produce a reactive quinone.  
     
     
         3 . The collagen scaffold according to  claim 2 , wherein said reactive catechol is a di-catechol.  
     
     
         4 . The collagen scaffold according to  claim 1 , wherein said collagen scaffold is embedded in a nordihydroguaiaretic acid (NDGA) bisquinone polymer matrix.  
     
     
         5 . The collagen scaffold according to  claim 1 , wherein said device comprises a sensor.  
     
     
         6 . The collagen scaffold according to  claim 5 , wherein said sensor is a glucose sensor.  
     
     
         7 . The collagen scaffold according to  claim 1 , wherein said collagen scaffold comprises open pores of between about 10 μm to about 200 μm in diameter (mean).  
     
     
         8 . The collagen scaffold according to  claim 7 , wherein the mean pore size of said collagen scaffold is about 60 μm or less in diameter.  
     
     
         9 . The collagen scaffold according to  claim 7 , wherein the mean pore size of said collagen scaffold is between about 40 μm and about 80 μm in diameter.  
     
     
         10 . The collagen scaffold according to  claim 1 , wherein said scaffold comprises at least one of an antimicrobial, anti-inflammatory, and/or angiogenic compound, drug or growth factor.  
     
     
         11 . A method for preparing a device for implantation into the body or tissue of a person or animal, said method comprising placing a biocompatible collagen scaffold or coating on said device, wherein said collagen scaffold or coating is embedded within a polymer matrix.  
     
     
         12 . The method according to  claim 11 , wherein said method comprises: 
 a) contacting said device with a collagen containing solution;    b) drying said collagen solution on said device; and    c) embedding said collagen on said device in a polymer matrix.    
     
     
         13 . The method according to  claim 12 , wherein said collagen is embedded in said matrix using a reactive catechol at a pH sufficient to produce a reactive quinone.  
     
     
         14 . The method according to  claim 13 , wherein said reactive catechol is a dicatechol.  
     
     
         15 . The method according to  claim 14 , wherein said dicatechol is NDGA.  
     
     
         16 . The method according to  claim 12 , wherein steps (a) and (b) of said method are repeated at least one time.  
     
     
         17 . The method according to  claim 12 , wherein steps (a) and (b) of said method are repeated at least two to four times.  
     
     
         18 . The method according to  claim 12 , wherein said drying step comprises freeze-drying.  
     
     
         19 . The method according to  claim 12 , wherein said collagen embedded in said matrix is subsequently freeze-dried.  
     
     
         20 . The method according to  claim 12 , wherein said collagen containing solution of step (a) comprises about 1% (w/v) collagen.  
     
     
         21 . The method according to  claim 12 , wherein said collagen scaffold comprises open pores of about 10 μm to about 200 μm in diameter (mean).  
     
     
         22 . The method according to  claim 21 , wherein the mean pore size of the collagen scaffold is about 60 μm or less in diameter.  
     
     
         23 . The method according to  claim 21 , wherein the mean pore size of the collagen scaffold is between 40 μm and 80 μm in diameter.  
     
     
         24 . A method for providing an implantable device with a biocompatible collagen coating or scaffold, wherein said collagen scaffold or coating is embedded within a polymer matrix, said method comprising: 
 a) contacting an implantable device structure with a collagen containing solution;    b) drying said collagen solution on said structure; and    c) embedding said collagen of said structure in a polymer matrix.    
     
     
         25 . The method according to  claim 24 , wherein said collagen is embedded in said matrix using a reactive catechol at a pH sufficient to produce a reactive quinone.  
     
     
         26 . The method according to  claim 25 , wherein said reactive catechol is a dicatechol.  
     
     
         27 . The method according to  claim 26 , wherein said dicatechol is NDGA.  
     
     
         28 . The method according to  claim 24 , wherein steps (a) and (b) of said method are repeated at least one time.  
     
     
         29 . The method according to  claim 24 , wherein steps (a) and (b) of said method are repeated a plurality of times.  
     
     
         30 . The method according to  claim 24 , wherein said drying step is freeze-drying.  
     
     
         31 . The method according to  claim 24 , wherein said collagen embedded in said matrix is subsequently freeze-dried.  
     
     
         32 . The method according to  claim 24 , wherein said collagen containing solution of step (a) comprises about 1% (w/v) collagen.  
     
     
         33 . The method according to  claim 24 , wherein said collagen scaffold comprises open pores of about 10 μm to about 200 μm in diameter (mean).  
     
     
         34 . The method according to  claim 33 , wherein the mean pore size of the collagen scaffold is about 60 μm or less in diameter.  
     
     
         35 . The method according to  claim 33 , wherein the mean pore size of the collagen scaffold is between 40 μm and 80 μm in diameter.  
     
     
         36 . A device having enhanced biocompatibility for implantation into the body or tissue of a person or animal, wherein said device comprises a biocompatible collagen scaffold or coating embedded within a polymer matrix.  
     
     
         37 . The device according to  claim 36 , wherein said scaffold and/or coating is treated with a cross-linking compound comprising a reactive catechol at a pH sufficient to produce a reactive quinone.  
     
     
         38 . The device according to  claim 37 , wherein said reactive catechol is a di-catechol.  
     
     
         39 . The device according to  claim 36 , wherein said collagen scaffold and/or coating is embedded in a nordihydroguaiaretic acid (NDGA) bisquinone polymer matrix.  
     
     
         40 . The device according to  claim 36 , wherein said device is a sensor.  
     
     
         41 . The device according to  claim 36 , wherein said device is a glucose sensor.  
     
     
         42 . The device according to  claim 36 , wherein said device comprises an epoxy coating underneath said collagen scaffold and/or coating.  
     
     
         43 . The device according to  claim 42 , wherein said epoxy coating is an epoxy-polyurethane coating.  
     
     
         44 . The device according to  claim 36 , wherein said scaffold comprises open pores of about 10 μm to about 200 μm in diameter (mean).  
     
     
         45 . The device according to  claim 44 , wherein the mean pore size of said collagen scaffold is about 60 μm or less in diameter.  
     
     
         46 . The device according to  claim 44 , wherein the mean pore size of said collagen scaffold is between about 40 μm and about 80 μm in diameter.  
     
     
         47 . The device according to  claim 36 , wherein said scaffold comprises an antimicrobial, anti-inflammatory, and/or angiogenic compound, drug or growth factor.

Join the waitlist — get patent alerts

Track US2008020012A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.